Literature DB >> 28150181

Empirical models for fitting of oral concentration time curves with and without an intravenous reference.

Michael Weiss1.   

Abstract

Appropriate model selection is important in fitting oral concentration-time data due to the complex character of the absorption process. When IV reference data are available, the problem is the selection of an empirical input function (absorption model). In the present examples a weighted sum of inverse Gaussian density functions (IG) was found most useful. It is shown that alternative models (gamma and Weibull density) are only valid if the input function is log-concave. Furthermore, it is demonstrated for the first time that the sum of IGs model can be also applied to fit oral data directly (without IV data). In the present examples, a weighted sum of two or three IGs was sufficient. From the parameters of this function, the model-independent measures AUC and mean residence time can be calculated. It turned out that a good fit of the data in the terminal phase is essential to avoid parameter biased estimates. The time course of fractional elimination rate and the concept of log-concavity have proved as useful tools in model selection.

Keywords:  Data fitting; Drug absorption; Inverse Gaussian function; Model selection; Oral administration

Mesh:

Substances:

Year:  2017        PMID: 28150181     DOI: 10.1007/s10928-017-9507-3

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  21 in total

1.  Application of a gamma model of absorption to oral cyclosporin.

Authors:  J Debord; E Risco; M Harel; Y Le Meur; M Büchler; G Lachâtre; C Le Guellec; P Marquet
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

2.  The relevance of residence time theory to pharmacokinetics.

Authors:  M Weiss
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

3.  A mechanism-based approach for absorption modeling: the Gastro-Intestinal Transit Time (GITT) model.

Authors:  Emilie Hénin; Martin Bergstrand; Joseph F Standing; Mats O Karlsson
Journal:  AAPS J       Date:  2012-06       Impact factor: 4.009

4.  The use of a sum of inverse Gaussian functions to describe the absorption profile of drugs exhibiting complex absorption.

Authors:  Chantal Csajka; David Drover; Davide Verotta
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

5.  Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies.

Authors:  Radojka M Savic; Daniël M Jonker; Thomas Kerbusch; Mats O Karlsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-07-26       Impact factor: 2.745

6.  Tail behavior of the failure rate functions of mixtures.

Authors:  H Block; H Joe
Journal:  Lifetime Data Anal       Date:  1997       Impact factor: 1.588

7.  Estimation of parameters for the elimination of an orally administered test substance with unknown absorption.

Authors:  Josef A Vogt; Christian Denzer
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-02-02       Impact factor: 2.745

8.  The use of Weibull distribution to describe the in vivo absorption kinetics.

Authors:  V K Piotrovskii
Journal:  J Pharmacokinet Biopharm       Date:  1987-12

9.  Effects of cranberry juice on pharmacokinetics of beta-lactam antibiotics following oral administration.

Authors:  Meng Li; Marilee A Andrew; Joanne Wang; David H Salinger; Paolo Vicini; Richard W Grady; Brian Phillips; Danny D Shen; Gail D Anderson
Journal:  Antimicrob Agents Chemother       Date:  2009-04-27       Impact factor: 5.191

10.  Population pharmacokinetic modelling of tramadol using inverse Gaussian function for the assessment of drug absorption from prolonged and immediate release formulations.

Authors:  Nina Brvar; Tatjana Mateović-Rojnik; Iztok Grabnar
Journal:  Int J Pharm       Date:  2014-07-08       Impact factor: 5.875

View more
  2 in total

1.  Analysis of Complex Absorption After Multiple Dosing: Application to the Interaction Between the P-glycoprotein Substrate Talinolol and Rifampicin.

Authors:  Michael Weiss; David Z D'Argenio; Werner Siegmund
Journal:  Pharm Res       Date:  2022-09-26       Impact factor: 4.580

2.  Usefulness of continuous probability distributions of rates for modelling radionuclide biokinetics in humans and animals.

Authors:  Igor Shuryak; Ekaterina Dadachova
Journal:  Sci Rep       Date:  2019-02-04       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.